146 related articles for article (PubMed ID: 8933356)
1. The incorporation and release of bovine serum albumin from poly-hydroxybutyrate-hydroxyvalerate microcapsules.
Atkins TW; Peacock J
J Microencapsul; 1996; 13(6):709-17. PubMed ID: 8933356
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of microcapsules using poly(ethylene adipate) and a blend of poly(ethylene adipate) with poly(hydroxybutyrate-hydroxyvalerate): incorporation and release of bovine serum albumin.
Atkins TW
Biomaterials; 1997 Jan; 18(2):173-80. PubMed ID: 9022966
[TBL] [Abstract][Full Text] [Related]
3. In vitro biodegradation of polyhydroxybutyrate-hydroxyvalerate microcapsules exposed to Hank's buffer, newborn calf serum, pancreatin and synthetic gastric juice.
Atkins TW; Peacock SJ
J Microencapsul; 1997; 14(1):35-49. PubMed ID: 8994074
[TBL] [Abstract][Full Text] [Related]
4. The incorporation and release of bovine serum albumin from poly(beta-hydroxybutyrate-hydroxyvalerate) microspheres.
Atkins TW; Peacock SJ
J Biomater Sci Polym Ed; 1996; 7(12):1065-73. PubMed ID: 8880438
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of microspheres using blends of poly(ethylene adipate) and poly(ethylene adipate)/poly(hydroxybutyrate-hydroxyvalerate) with poly(caprolactone): incorporation and release of bovine serum albumin.
Atkins TW
J Biomater Sci Polym Ed; 1997; 8(11):833-45. PubMed ID: 9342650
[TBL] [Abstract][Full Text] [Related]
6. Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.
Brunner CT; Baran ET; Pinho ED; Reis RL; Neves NM
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):498-507. PubMed ID: 21376545
[TBL] [Abstract][Full Text] [Related]
7. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.
Embleton JK; Tighe BJ
J Microencapsul; 1993; 10(3):341-52. PubMed ID: 8377092
[TBL] [Abstract][Full Text] [Related]
8. Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsules.
Gürsel I; Hasirci V
J Microencapsul; 1995; 12(2):185-93. PubMed ID: 7629661
[TBL] [Abstract][Full Text] [Related]
9. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin.
Zheng CH; Liang WQ; Li F; Zhang YP; Fang WJ
Pharmazie; 2005 Jun; 60(6):434-8. PubMed ID: 15997832
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system.
Dai C; Wang B; Zhao H; Li B; Wang J
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):205-10. PubMed ID: 16446077
[TBL] [Abstract][Full Text] [Related]
11. BSA-FITC-loaded microcapsules for in vivo delivery.
Kim BS; Oh JM; Kim KS; Seo KS; Cho JS; Khang G; Lee HB; Park K; Kim MS
Biomaterials; 2009 Feb; 30(5):902-9. PubMed ID: 19027943
[TBL] [Abstract][Full Text] [Related]
12. Polymers for biodegradable medical devices. IX: Microencapsulation studies; effects of polymer composition and process parameters on poly-hydroxybutyrate-hydroxyvalerate microcapsule morphology.
Embleton JK; Tighe BJ
J Microencapsul; 1992; 9(1):73-87. PubMed ID: 1613646
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protein-loaded poly(epsilon-caprolactone) microparticles based on a factorial design.
Lin WJ; Huang LI; Chang RR
J Microencapsul; 2001; 18(2):183-9. PubMed ID: 11253935
[TBL] [Abstract][Full Text] [Related]
14. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
[TBL] [Abstract][Full Text] [Related]
15. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin.
Park SJ; Lee YM; Hong SK
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):211-5. PubMed ID: 16413177
[TBL] [Abstract][Full Text] [Related]
16. Protein-loaded poly(epsilon-caprolactone) microparticles. I. Optimization of the preparation by (water-in-oil)-in water emulsion solvent evaporation.
Youan BB; Benoit MA; Baras B; Gillard J
J Microencapsul; 1999; 16(5):587-99. PubMed ID: 10499839
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release.
Sah HK; Toddywala R; Chien YW
J Microencapsul; 1995; 12(1):59-69. PubMed ID: 7730957
[TBL] [Abstract][Full Text] [Related]
18. Polycaprolactone and bovine serum albumin based nanofibers for controlled release of nerve growth factor.
Valmikinathan CM; Defroda S; Yu X
Biomacromolecules; 2009 May; 10(5):1084-9. PubMed ID: 19323510
[TBL] [Abstract][Full Text] [Related]
19. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol.
Kim KS; Park SJ
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):404-9. PubMed ID: 20034769
[TBL] [Abstract][Full Text] [Related]
20. Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres.
Atkins TW; Peacock SJ; Yates DJ
J Microencapsul; 1998; 15(1):31-44. PubMed ID: 9463805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
